H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN) [Yahoo! Finance]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Yahoo! Finance
Wainwright maintained its Buy rating for Legend Biotech Corp. (NASDAQ:LEGN). The firm has projected a target price of $50, which yields more than 109% potential upside for investors. It highlighted the company's CAR-T therapies and attributed its bullish view of the stock to the ongoing progress related to those programs. It noted that the trial data for vivo CD19/CD20 CAR-T will be revealed soon. Tonhom1009/Shutterstock.com The firm also reflected on the management's strong indication of critical medical meeting readouts, which appear to be imminent in the foreseeable future. These relate to the preliminary dosages given to patients during last summer, leading to 6 months of data for patients who have undergone the longest treatments. H.C. Wainwright also acknowledged the continued strength shown by the CARVYKTI electronic order book during the entirety of the first quarter. With favorable operational momentum witnessed from January through April, the firm labelled the IQVIA pr
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Legend Biotech to Host Investor Conference Call on First Quarter 2026 ResultsGlobeNewswire
- Legend Biotech: Undervalued Leader In The CAR-T Race [Seeking Alpha]Seeking Alpha
- Legend Biotech CARVYKTI Milestones Contrast With Mixed Long Term Share Returns [Yahoo! Finance]Yahoo! Finance
- Legend Biotech (LEGN) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.MarketBeat
- Why Legend Biotech Stock Crushed the Market on Monday [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
LEGN
Sec Filings
- 4/14/26 - Form 6-K
- 3/27/26 - Form 4
- 3/26/26 - Form 144
- LEGN's page on the SEC website